Saturday, July 15, 2023 7:23:03 AM
So I hope that our intended partner in our business combination is PCI Pharma, and that we can conclude negotiations, and perhaps end up with an equity stake in a company that could become our product manufacturer, and more.
Whether there is any intent on using PCI Pharma in this capacity, or not, I couldn't say. But our success can't be held hostage. There are other CDMO's, and perhaps Cenexi is still a possibility. We need a Plan B, if not as a business combination candidate, then at least as a CDMO.
I fully support dedicating up to 40% of the company to a business combination into an entity that we will co-own, if that means we have ownership rights over the manufacture of our product. If the Baudax investment leads to Recro, that could also be our key to a CDMO foothold.
I think that management has amazing foresight, and I'm not used to seeing them at an impasse, which I hope they can overcome.
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM